CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development
CytoReason, Pfizer sign $110m extended AI-based drug development deal
CytoReason Expands its 2019 Collaboration with Pfizer for AI Drug Development
Touting nine-figure deal package, Pfizer extends collaboration with AI partner
CytoReason Extends multi-Year Partnership with Pfizer
Epic hits a crossroads, judge rules on UnitedHealth’s Change bid, & Meta faces health data pressure
CytoReason Shoots For $110M Net With Pfizer Partnership
CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development
Sept. 20 Quick Takes: Rocket gains gene therapy via Renovacor takeout
CytoReason announces expanded collaboration with Pfizer
